C4 Therapeutics, Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
104
IPO date
Oct 2, 2020

C4 Therapeutics is a drug-development company focused on targeted protein degradation. Instead of trying to block a disease-causing protein, it designs small-molecule medicines that tag that protein for removal by the cell’s own cleanup system. Its main work is in oncology, where it builds drug candidates aimed at cancers driven by hard-to-treat proteins.

The company makes money in two main ways: by collaborating with larger pharmaceutical partners and by developing its own drug pipeline. In partnerships, it can receive research funding, milestone payments, and royalties if a partnered drug reaches the market. If its own programs succeed, it could also earn future product sales or licensing income, though that depends on clinical and regulatory progress.

What makes C4 different is its focus on degradation rather than simple inhibition. That approach is meant to address proteins that are difficult to drug with standard medicines, giving the company a distinct role in the biotech value chain as a designer of early-stage precision medicines rather than a traditional drug seller.

C4 Therapeutics, Inc Investor Relations

Address
490 Arsenal Way, Suite 120
Watertown, Massachusetts
United States of America

Business Segments

Drug discovery platform

C4 Therapeutics designs small-molecule medicines that use targeted protein degradation to break down disease-causing proteins. The company runs early research, advances drug candidates, and may out-license programs to pa...

Customers and revenue model

Management

Mr. Andrew J. Hirsch M.B.A.

CEO, President & Director

Biography unavailable

Dr. Kenneth C. Anderson M.D., Ph.D.

Co-Founder, Independent Director & Member of Scientific Advisory Board

Biography unavailable

Dr. Leonard M. J. Reyno M.D.

Chief Medical Officer

Biography unavailable

Dr. Nathanael S. Gray Ph.D.

Co-Founder & Member of Scientific Advisory Board

Biography unavailable

Ms. Kendra Adams

CFO & Treasurer

Biography unavailable

Mr. Mark Mossler

Chief Accounting Officer

Biography unavailable

Ms. Paige Mahaney Ph.D.

Chief Scientific Officer

Biography unavailable

Ms. Courtney Solberg

Senior Manager of Investor Relations

Biography unavailable

Ms. Jolie M. Siegel J.D.

Chief Legal Officer & Corporate Secretary

Biography unavailable

Ms. Kelly A. Schick

Chief People Officer

Biography unavailable

1 / 10